Fig. 7
From: Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer
The inhibitory effect of CDDP/resiquimod/PLG-g-mPEG on cancers in the boy. 1 for negative control group; 2 for resiquimod group; 3 for CDDP group; 4 for PLG-g-mPEG group; 5 for CDDP/resiquimod/PLG-g-mPEG group; A for mouse weight change; B for the tumor weight and the inhibition rate of mice; C for tumor volume change